Latest news

Thumbnail image for EU expands scope of Amgen’s Xgeva

EU expands scope of Amgen’s Xgeva

European regulators have expanded the treatment scope of Amgen’s Xgeva to include the prevention of skeletal-related events in adults with multiple myeloma.

4th April 2018

Thumbnail image for EU reviews first PARP inhibitor for breast cancer

EU reviews first PARP inhibitor for breast cancer

MSD and AstraZeneca’s Lynparza will be the first PARP inhibitor to be reviewed in Europe for the treatment of breast cancer, after the European Medicines Agency validated the drug’s marketing application in this setting.

4th April 2018

Thumbnail image for Communications Team of the Year opens for entry - with two new categories

Communications Team of the Year opens for entry - with two new categories

PharmaTimes Communications Team of the Year has a long history of being the only pharma industry award that tests the competencies and potential of communications agency teams, benchmarking talent agency side. Such is the popularity of the competition that the decision has been taken to increase the number of categories and with it, the opportunity for agencies – and individuals - to shine.

29th March 2018

Thumbnail image for Research backs halving chemo after bowel cancer surgery

Research backs halving chemo after bowel cancer surgery

Some patients receiving chemotherapy after surgery for bowel cancer might only need three months of treatment rather than the six months currently given, according to new research published in Lancet Oncology.

29th March 2018

Thumbnail image for EU ready to review Shire’s lanadelumab for HAE

EU ready to review Shire’s lanadelumab for HAE

EU regulators have validated Shire’s application to market its experimental hereditary angioedema (HAE) drug lanadelumab, indicating that there is sufficient data to begin a priority review.

29th March 2018

Thumbnail image for Takeda eyes up Shire

Takeda eyes up Shire

Takeda has revealed that it is considering making a move on Shire to add ballast to its core therapeutic areas.

29th March 2018

Previous  --   1 2 3 4 5 6 7 8 9 10   --  Next

Download our apps

Go to the App Store or Google Play and search for 'PharmaTimes' to download our free app.

Go to the App Store or Google Play and search for 'PharmaTimes' to download our free app.

Download